AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.5 MB)
Collect
AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Elucidation of the hepatoprotective effect and mechanism of Melastoma dodecandrum Lour. based on network pharmacology and experimental validation

Jinfeng WangaLinyuan WangbZhihao ZhangcMin WudWenting FeibZhihui YangeJianjun Zhanga( )
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China
Medical College, Yangzhou University, Yangzhou, 225001, China
Department of Emergency Medicine, University of Florida, Gainesville, 32611, USA

Peer review under responsibility of Beijing University of Chinese Medicine.

Show Author Information

Abstract

Objective

To systematically explore the effect and mechanism of melastomatis dodecandri herba (Melastoma dodecandrum Lour.) in the treatment of hepatitis based on network pharmacology.

Method

We evaluated the hepatoprotective effects of M. dodecandrum in concanavalin A (Con A)-induced hepatitis in mice by assessing survival rate, histological analysis, serum transaminases, and related cytokines. Then the mechanism of action was predicted by a network pharmacology-based strategy. Based on the results, we measured the hepatic expression of related genes at mRNA level and proteins related to the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) and nuclear factor-kappa B (NF-кB) pathways.

Results

Our study results clearly demonstrated that M. dodecandrum pretreatment significantly alleviated liver injury. This was demonstrated by an increase in survival rate, decreased severity of liver damage, and reduced serum transaminase levels compared with those in the Con A group. Moreover, M. dodecandrum significantly reduced the serum levels of tumor necrosis factor-α, interleukin-6, and interferon-γ and increased the liver levels of superoxide dismutase, which indicated that M. dodecandrum exhibits anti-inflammatory and antioxidant activities. On the basis of network pharmacology, 50 nodes were selected as major hubs based on their topological importance. Pathway enrichment analyses indicated that the putative targets of M. dodecandrum mostly participate in various pathways associated with the anti-inflammation response, which implies the underlying mechanism by which M. dodecandrum acts on hepatitis. Real-time fluorescent quantitative PCR analysis showed that M. dodecandrum downregulates the mRNA expression of interleukin-6, Toll-like receptor 7, interleukin-1 receptor-associated kinase-4, NF-кB and tumor necrosis factor-α in liver tissues. Western blotting showed that M. dodecandrum pretreatment protected against inflammation through activating the PI3K-Akt pathway by upregulating phosphorylated Akt (p-Akt) expression and suppressing NF-кB activation by inhibiting the phosphorylation of IKK, IκBα, and p65.

Conclusion

The present work demonstrated the hepatoprotective effects of M. dodecandrum by regulating the PI3K/Akt and NF-кB pathways in Con A-induced mice, which provide insights into the treatment of hepatitis using M. dodecandrum.

References

1

Catherine FX, Piroth L. Hepatitis B virus vaccination in HIV-infected people: a review. Hum Vaccines Immunother. 2017;13(6):1-10.

2

Sadlier C, Madden K, O'Gorman S, et al. Development of chronic hepatitis B infection in a hepatitis B vaccine responder. Int J STD AIDS. 2017;28(5):526-528.

3

Shire NJ. Cure strategies for hepatitis B virus: the promise of immunotherapy. Clin Pharmacol Drug Dev. 2017;6(2):186-194.

4
TiegsGHentschelJWendelAA T cell-dependent experimental liver injury in mice inducible by concanavalin AJ Clin Invest1992901196203

Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90(1):196-203.

10.1172/JCI115836
5
TangHHLiHLLiYXProtective effects of a traditional Chinese herbal formula Jiang-Xian HuGan on concanavalin A-induced mouse hepatitis via NF-κB and Nrf2 signaling pathwaysJ Ethnopharmacol2018217118125

Tang HH, Li HL, Li YX, et al. Protective effects of a traditional Chinese herbal formula Jiang-Xian HuGan on concanavalin A-induced mouse hepatitis via NF-κB and Nrf2 signaling pathways. J Ethnopharmacol. 2018;217:118-125.

10.1016/j.jep.2018.02.003
6

Yoshizumi Y, Yukawa H, Iwaki R, et al. Immunomodulatory effects of adipose tissue-derived stem cells on concanavalin A-induced acute liver injury in mice. Cell Med. 2017;9(1):21-33.

7
BaiXTYangPXZhouQLThe protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitroBr J Pharmacol20171744156

Bai XT, Yang PX, Zhou QL, et al. The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro. Br J Pharmacol. 2017;174:41-56.

10.1111/bph.13645
8

Shimizu Y, Mashima-Nemoto T, Hazawa M, et al. The hepatoprotective effect of lycopene on Con A-induced liver injury in mice. Pharmazie. 2018;73(7):393-395.

9

Yu ZC, Lin XX, Su JQ, et al. Advance in Melastoma dodecandrum Lour. Researches. Med Plants. 2011;2(12):63-67.

10

Wang JF, Zhang PH, Wang YT, et al. Research progress of Melastoma dodecandrum Lour. Chin Tradit Herb Drugs. 2018;49(5):1211-1219 [Chinese].

11

Li QL, Cheng TJ, Wang YL, et al. PubChem as a public resource for drug discovery. Drug Discov Today. 2010;15(23):1052-1057.

12

Daina A, Michielin O, Zoete V. Swiss target prediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(1):357-364.

13

Stelzer G, Rosen N, Plaschkes I, et al. The gene cards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. 2016;54:1-33.

14

Amberger JS, Hamosh A. Searching online mendelian inheritance in man (OMIM): a knowledge base of human genes and genetic phenotypes. Curr Protoc Bioinform. 2017;58:1-12.

15

Chen HB, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinf. 2011;12:35.

16

Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(1):607-613.

17

Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-2504.

18
HuangLLiuTGJiangMNetwork pharmacology-based prediction and verification of the mechanism for Bushen Chengyun granule on low endometrial receptivityJ Tradit Chin Med Sci202071211

Huang L, Liu TG, Jiang M, et al. Network pharmacology-based prediction and verification of the mechanism for Bushen Chengyun granule on low endometrial receptivity. J Tradit Chin Med Sci. 2020;7(1):2-11.

10.1016/j.jtcms.2020.01.002
19
XuMZhangLLLiPNetwork pharmacology used to decode potential active ingredients in Ferula assafoetida and mechanisms for the application to Alzheimer's diseaseJ Tradit Chin Med Sci202072199209

Xu M, Zhang LL, Li P, et al. Network pharmacology used to decode potential active ingredients in Ferula assafoetida and mechanisms for the application to Alzheimer's disease. J Tradit Chin Med Sci. 2020;7(2):199-209.

10.1016/j.jtcms.2020.04.002
20

Wang JF, Jia ZY, Zhang ZH, et al. Analysis of chemical constituents of Melastoma dodecandrum Lour. by UPLC-ESI-Q-Exactive focus-MS/MS. Molecules. 2017;22(3):476.

21

Yang XJ, Han XN, Zhang YF, et al. Investigation of analgesic mechanisms of Bupleuri Radix with network pharmacology. Chin Pharmaceut J. 2019;54(2):98-104 [Chinese].

22

Pu Q, Xu WL, Li N, et al. Network pharmacology-based study on material basis and mechanism of Qikui Granules against diabetic nephropathy. Chin Tradit Herb Drugs. 2019;50(23):5767-5777 [Chinese].

23

Zhou SS, Ai ZZ, Li WN, et al. Active components and mechanism of Rhei Radix et Rhizoma on renal fibrosis based on network pharmacology. Chin J Exp Tradit Med Formul. 2020;26(10):163-172 [Chinese].

24

Wu LC, Chen Y, Yi J, et al. Mechanism of action of Bu-Fei-Yi-Shen formula in treating chronic obstructive pulmonary disease based on network pharmacology analysis and molecular docking validation. BioMed Res Int. 2020:9105972.

25

Yu GH, Wang WB, Wang X, et al. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis. BMC Compl Alternative Med. 2018;18(1):292-313.

26

Wang HX, Liu M, Weng SY, et al. Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol. 2012;18(2):119-125.

27
XuWChenSHZhongGSEffects of a combination of Japanese raisin tree seed and flower of lobed kudzuvine against acute alcohol-induced liver injury in miceJ Tradit Chin Med Sci2020715967

Xu W, Chen SH, Zhong GS, et al. Effects of a combination of Japanese raisin tree seed and flower of lobed kudzuvine against acute alcohol-induced liver injury in mice. J Tradit Chin Med Sci. 2020;7(1):59-67.

10.1016/j.jtcms.2020.01.008
28

Hanley A, Williams K, Festa A. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004;53:2623-2632.

29
MillerMLSunYFuYXCutting edge. B and T lymphocyte attenuator signaling on NKT cells inhibits cytokine release and tissue injury in early immune responsesJ Immunol20091833236

Miller ML, Sun Y, Fu YX. Cutting edge. B and T lymphocyte attenuator signaling on NKT cells inhibits cytokine release and tissue injury in early immune responses. J Immunol. 2009;183:32-36.

10.4049/jimmunol.0900690
30

Shirin H, Aeed H, Alin A, et al. Inhibition of immune-mediated concanavalin A-induced liver damage by free-radical scavengers. Dig Dis Sci. 2010;55(2):268-275.

31

Wardi J, Ernst O, Lilja A, et al. 3-Aminobenzamide prevents concanavalin A-induced acute hepatitis by an anti-inflammatory and anti-oxidative mechanism. Dig Dis Sci. 2018;63(12):3382-3397.

32
KaishoTAkiraSToll-like receptor function and signalingJ Allergy Clin Immunol20061175979987

Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117(5):979-987.

10.1016/j.jaci.2006.02.023
33

Zhang YL, Guo YJ, Lv K, et al. Molecular cloning and functional characterization of porcine toll-like receptor 7 involved in recognition of single-stranded RNA virus/ssRNA. Mol Immunol. 2008;45(4):1184-1190.

34

Lee J, Chuang TH, Redecke V, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of toll-like receptor 7. Proc Natl Acad Sci USA. 2003;100(11):6646-6651.

35

Lund JM, Alexopoulou L, Sato A, et al. Recognition of single-stranded RNA virus es by Toll-like receptor 7. Proc Natl Acad Sci USA. 2004;101(15):5598-5603.

36

Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303(5663):1526-1529.

37

Diebold SS, Kaisho T, Hemmi H, et al. Innate antiviral responses by means of TLR7-mediated recognition of single stranded RNA. Science. 2004;303(5663):1529-1531.

38

Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7-MyD88-dependent signaling pathway. Nat Immunol. 2002;3(2):196-200.

39
SuzukiNSuzukiSMillarDGA critical role for the innate immune signaling molecule IRAK-4 in T cell activationScience2006311567919271932

Suzuki N, Suzuki S, Millar DG, et al. A critical role for the innate immune signaling molecule IRAK-4 in T cell activation. Science. 2006;311(5679):1927-1932.

10.1126/science.1124256
40

Wang CP, Li JL, Zhang LZ, et al. Isoquercetin protects cortical neurons from oxygen-glucose deprivation-reperfusion induced injury via suppression of TLR4-NF-кB signal pathway. Eurochem Int. 2013;63(8):741-749.

41
DuLYeXTLiMMMechanisms of traditional Chinese medicines in the treatment of allergic rhinitis using a network biology approachJ Tradit Chin Med Sci2021818289

Du L, Ye XT, Li MM, et al. Mechanisms of traditional Chinese medicines in the treatment of allergic rhinitis using a network biology approach. J Tradit Chin Med Sci. 2021;8(1):82-89.

10.1016/j.jtcms.2016.11.007
42

Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27-42.

43

Martelli AM, Nyakern M, Tabellini G, et al. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia. 2006;20(6):911-928.

44

Zandi E, Rothwarf DM, Delhase M, et al. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 1991;91(2):243-252.

45

Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov. 2004;3(1):17-26.

46
The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
47

Luedde T, Schwabe RF. NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(2):108-118.

Journal of Traditional Chinese Medical Sciences
Pages 47-58
Cite this article:
Wang J, Wang L, Zhang Z, et al. Elucidation of the hepatoprotective effect and mechanism of Melastoma dodecandrum Lour. based on network pharmacology and experimental validation. Journal of Traditional Chinese Medical Sciences, 2022, 9(1): 47-58. https://doi.org/10.1016/j.jtcms.2021.12.003

487

Views

9

Downloads

0

Crossref

1

Scopus

Altmetrics

Received: 22 April 2021
Revised: 30 December 2021
Accepted: 30 December 2021
Published: 03 January 2022
© 2022 Beijing University of Chinese Medicine.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return